@article{2eb299dabc9d4a17bea1a2e1b38d4ae3,
title = "Randomly distributed K14{\th} breast tumor cells polarize to the leading edge and guide collective migration in response to chemical and mechanical environmental cues",
abstract = "Collective cell migration is an adaptive, coordinated interactive process involving cell–cell and cell–extracellular matrix (ECM) microenvironmental interactions. A critical aspect of collective migration is the sensing and establishment of directional movement. It has been proposed that a subgroup of cells known as leader cells localize at the front edge of a collectively migrating cluster and are responsible for directing migration. However, it is unknown how and when leader cells arrive at the front edge and what environmental cues dictate leader cell development and behavior. Here, we addressed these questions by combining a microfluidic device design that mimics multiple tumor microenvironmental cues concurrently with biologically relevant primary, heterogeneous tumor cell organoids. Prior to migration, breast tumor leader cells (K14{\th}) were present throughout a tumor organoid and migrated (polarized) to the leading edge in response to biochemical and biomechanical cues. Impairment of either CXCR4 (biochemical responsive) or the collagen receptor DDR2 (biomechanical responsive) abrogated polarization of leader cells and directed collective migration. This work demonstrates that K14{\th} leader cells utilize both chemical and mechanical cues from the microenvironment to polarize to the leading edge of collectively migrating tumors.",
author = "Hwang, {Priscilla Y.} and Audrey Brenot and King, {Ashley C.} and Longmore, {Gregory D.} and George, {Steven C.}",
note = "Funding Information: The authors would like to thank the Washington University Center for Cellular Imaging (WUCCI) for microscopy help. The authors would also like to thank Dr. Drew Elizabeth Glaser, Dr. Mary-Kathryn Sewell-Loftin, Dr. Venktesh Shirure, and Benjamin Aunins for their help and advice. G.D. Longmore received support from NIH R01CA196205 and U54 CA210173. S.C. George received start-up funds from the School of Engineering at Washington University in St. Louis. P.Y. Hwang received an American Cancer Society Postdoctoral Fellowship 131342-PF-17-238-01-CSM and a WM Keck Foundation Postdoctoral Fellowship. Funding Information: The Longmore laboratory currently receives funding from Pfizer, Inc. None of the work presented herein was supported by these funds. Funding Information: G.D. Longmore received support from NIH R01CA196205 and U54 CA210173. S.C. George received start-up funds from the School of Engineering at Washington University in St. Louis. P.Y. Hwang received an American Cancer Society Postdoctoral Fellowship 131342-PF-17-238-01-CSM and a WM Keck Foundation Postdoctoral Fellowship. Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",
year = "2019",
month = apr,
day = "15",
doi = "10.1158/0008-5472.CAN-18-2828",
language = "English",
volume = "79",
pages = "1899--1912",
journal = "Cancer Research",
issn = "0008-5472",
number = "8",
}